Cargando…
SARS-CoV-2 and the pandemic of COVID-19
SARS-CoV-2 is a virus that is the cause of a serious life-threatening disease known as COVID-19. It was first noted to have occurred in Wuhan, China in November 2019 and the WHO reported the first case on December 31, 2019. The outbreak was declared a global pandemic on March 11, 2020 and by May 30,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016996/ https://www.ncbi.nlm.nih.gov/pubmed/32788312 http://dx.doi.org/10.1136/postgradmedj-2020-138386 |
_version_ | 1784907487207489536 |
---|---|
author | Adil, Md Tanveer Rahman, Rumana Whitelaw, Douglas Jain, Vigyan Al-Taan, Omer Rashid, Farhan Munasinghe, Aruna Jambulingam, Periyathambi |
author_facet | Adil, Md Tanveer Rahman, Rumana Whitelaw, Douglas Jain, Vigyan Al-Taan, Omer Rashid, Farhan Munasinghe, Aruna Jambulingam, Periyathambi |
author_sort | Adil, Md Tanveer |
collection | PubMed |
description | SARS-CoV-2 is a virus that is the cause of a serious life-threatening disease known as COVID-19. It was first noted to have occurred in Wuhan, China in November 2019 and the WHO reported the first case on December 31, 2019. The outbreak was declared a global pandemic on March 11, 2020 and by May 30, 2020, a total of 5 899 866 positive cases were registered including 364 891 deaths. SARS-CoV-2 primarily targets the lung and enters the body through ACE2 receptors. Typical symptoms of COVID-19 include fever, cough, shortness of breath and fatigue, yet some atypical symptoms like loss of smell and taste have also been described. 20% require hospital admission due to severe disease, a third of whom need intensive support. Treatment is primarily supportive, however, prognosis is dismal in those who need invasive ventilation. Trials are ongoing to discover effective vaccines and drugs to combat the disease. Preventive strategies aim at reducing the transmission of disease by contact tracing, washing of hands, use of face masks and government-led lockdown of unnecessary activities to reduce the risk of transmission. |
format | Online Article Text |
id | pubmed-10016996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-100169962023-05-23 SARS-CoV-2 and the pandemic of COVID-19 Adil, Md Tanveer Rahman, Rumana Whitelaw, Douglas Jain, Vigyan Al-Taan, Omer Rashid, Farhan Munasinghe, Aruna Jambulingam, Periyathambi Postgrad Med J Review SARS-CoV-2 is a virus that is the cause of a serious life-threatening disease known as COVID-19. It was first noted to have occurred in Wuhan, China in November 2019 and the WHO reported the first case on December 31, 2019. The outbreak was declared a global pandemic on March 11, 2020 and by May 30, 2020, a total of 5 899 866 positive cases were registered including 364 891 deaths. SARS-CoV-2 primarily targets the lung and enters the body through ACE2 receptors. Typical symptoms of COVID-19 include fever, cough, shortness of breath and fatigue, yet some atypical symptoms like loss of smell and taste have also been described. 20% require hospital admission due to severe disease, a third of whom need intensive support. Treatment is primarily supportive, however, prognosis is dismal in those who need invasive ventilation. Trials are ongoing to discover effective vaccines and drugs to combat the disease. Preventive strategies aim at reducing the transmission of disease by contact tracing, washing of hands, use of face masks and government-led lockdown of unnecessary activities to reduce the risk of transmission. Oxford University Press 2020-08-11 /pmc/articles/PMC10016996/ /pubmed/32788312 http://dx.doi.org/10.1136/postgradmedj-2020-138386 Text en © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Review Adil, Md Tanveer Rahman, Rumana Whitelaw, Douglas Jain, Vigyan Al-Taan, Omer Rashid, Farhan Munasinghe, Aruna Jambulingam, Periyathambi SARS-CoV-2 and the pandemic of COVID-19 |
title | SARS-CoV-2 and the pandemic of COVID-19 |
title_full | SARS-CoV-2 and the pandemic of COVID-19 |
title_fullStr | SARS-CoV-2 and the pandemic of COVID-19 |
title_full_unstemmed | SARS-CoV-2 and the pandemic of COVID-19 |
title_short | SARS-CoV-2 and the pandemic of COVID-19 |
title_sort | sars-cov-2 and the pandemic of covid-19 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016996/ https://www.ncbi.nlm.nih.gov/pubmed/32788312 http://dx.doi.org/10.1136/postgradmedj-2020-138386 |
work_keys_str_mv | AT adilmdtanveer sarscov2andthepandemicofcovid19 AT rahmanrumana sarscov2andthepandemicofcovid19 AT whitelawdouglas sarscov2andthepandemicofcovid19 AT jainvigyan sarscov2andthepandemicofcovid19 AT altaanomer sarscov2andthepandemicofcovid19 AT rashidfarhan sarscov2andthepandemicofcovid19 AT munasinghearuna sarscov2andthepandemicofcovid19 AT jambulingamperiyathambi sarscov2andthepandemicofcovid19 |